Archean Chemical Industries Ltd(ACI)

NSE: ACIBSE: 543657

₹ 479.65+4.08%refreshed 23 Oct, 03:53 pm ISTMarket cap: ₹ 5,922 crNext results: 29 Oct 2026Website: www.archeanchemicals.comUpdated: 24 Oct 2026

About

Archean Chemical Industries operates India's first integrated facility producing industrial salt, bromine and sulphate of potash (SOP) from natural sea brine, at Hajipir in Gujarat. It says it is India's largest manufacturer and exporter of bromine and a leading exporter of industrial salt. FY26 revenue was Rs 1,081.05 cr. Through subsidiaries it also makes bromine derivatives and oilfield chemicals, and it is building a silicon carbide (SiC) compound semiconductor fab via SiCSem.^[1][2]

Business segments

Industrial salt was the largest segment in Q1 FY27, with revenue of INR 1,713 mn on volumes of 982,000 tons. It made up ~70% of standalone revenue in Q3 FY26.^[3]
Bromine (standalone) revenue was INR 1,333 mn in Q1 FY27, up 58% YoY, at realisations of ~INR 300/kg.^[3]
Bromine derivatives (subsidiary Acume Chemicals) revenue was ~INR 298 mn in Q1 FY27, up 28% YoY, at ~40% capacity utilisation.^[3]
SOP revenue was INR 113 mn in Q1 FY27, versus INR 35 mn for the full year FY26, as trial production volumes rose.^[3]
Idealis Mudchemie (oilfield chemicals) had revenue of INR 3.5 mn and an EBITDA loss of INR 13.4 mn in Q1 FY27 while its plants completed customer trials.^[3]
Segment revenue in FY24: Marine Chemicals India Rs 370.14 cr vs Rest of the world Rs 959.44 cr.^[4]

Products and portfolio

Makes Grade 1 industrial salt with purity above 99.5% NaCl (FY26).^[1]
Says it is India's only large-scale producer of fertiliser-grade, water-soluble SOP made through the natural sea brine route (FY26).^[1]
Acume's core bromine derivatives include pharma-grade NPBr, CABR variants, PBR3 and zinc bromide. As of Q3 FY26, around 15 new products were in customer trials.^[3]
Idealis Mudchemie's product lines include starch, PAC (polyanionic cellulose), bentonite and barite for the oilfield chemicals market.^[3]
About 60-70% of bromine volumes are sold under long-term contracts. Most of these were renegotiated upward in FY26.^[3]

Operations and capacity

Installed capacity as of FY26: industrial salt 7.5 MM MT, liquid bromine 42,000 MT and SOP 1,32,000 MT per annum. All come from a single plant at Hajipir, Gujarat.^[1]
Uses brine reserves in the Rann of Kutch and has a captive port (FY26).^[1]
Bromine's actual run-rate is ~20,000-21,000 MT/year (Q4 FY26 call). Debottlenecking can raise this to 25,000 MT, with a longer-term target of 40,000 MT.^[5]
Acume runs a 28,000 MTPA bromine derivatives facility; Phase 1 was commissioned in 2024. It ran at ~40% utilisation in Q1 FY27, versus 30-40% in Q3 FY26.^[1][3]
Idealis acquired five idle oilfield chemical units through the NCLT process. Three have begun initial commercial operations; the other two are expected to be commissioned next financial year (FY26 report).^[1]
SOP Phase 1 plant-scale trials were completed in June 2026. Phase 2 trials are targeted by end of Q3 FY27.^[3]
Brine field Phase 1 expansion was largely complete as of Q1 FY27. Commissioning may be brought forward to post-monsoon FY27.^[3]

Key operating numbers

FY26 volumes: industrial salt 4.2 Mln tonnes and bromine 13,263 tonnes.^[1]
Bromine sales were 4,175 tons in Q1 FY27, the highest in five quarters. FY26 volume was 13,263 MT, down ~24.8% YoY.^[3]
Bromine realisation was ~INR 300/kg in Q1 FY27, up ~50% YoY.^[3]
Industrial salt volumes were 982,000 tons in Q1 FY27, down 12% YoY. Logistics disruptions and West Asia deferments were the causes.^[3]
Acume EBITDA was INR 19 mn in Q1 FY27, versus a loss of INR 27 mn in Q1 FY26. Its FY26 volume was ~5,300 tons.^[3]
Q1 FY27 bromine output lost ~175-200 tons to grid outages and ~150 tons to planned debottlenecking shutdowns.^[3]

Customers and exports

Had 40 domestic and 25 global customers as of FY26.^[1]
Industrial salt is sold mainly to chlor-alkali customers in Southeast Asia, China, the Middle East and the Gulf (FY26).^[1]
Key West Asia salt customer QVC deferred orders in Q1 FY27. QVC deferrals had also cost ~120,000 tons of volume in Q4 FY26.^[3]
Salt exports faced vessel shortages in Q1 FY27, and sea freight rose 30-35% YoY.^[3]
The FY26 report notes that the West Asia conflict and Hormuz disruption are raising energy and freight costs and affecting chlor-alkali salt demand.^[1]

Expansion and capex

SiCSem is building a SiC compound semiconductor fab and ATMP facility in Odisha with capex of Rs 2,067 cr. It is the only compound semiconductor project of this kind approved under the India Semiconductor Mission (ISM).^[1]
SiCSem received ISM approval in August 2025 and held its groundbreaking in November 2025. The ISM fiscal support agreement was signed on May 11, 2026.^[1][3]
SiCSem Phase 1 is designed for 60,000 wafers/year and 96 mn units of packaging at Bhubaneswar.^[6]
About 15-20% of SiCSem's USD 249 mn capex had been incurred by Q1 FY27.^[3]
Signed an MoU with Gujarat for a captive salt jetty with throughput of 7 MMTPA (FY26).^[1]
Flame retardant Phase 2 is broadly targeted for end-FY27 (Q3 FY26 call).^[7]

Investments and recent developments

On 22 Oct 2026, CRISIL downgraded Rs 1,531 crore of long-term bank facilities from CRISIL A/Negative to CRISIL A-/Stable.^[8]
Holds ~22.24% of Clas-SiC Wafer Fab Limited, UK, which is SiCSem's technology partner (FY26).^[1]
Committed USD 12 Mln for ~18.14% of zinc-bromide battery developer Offgrid Energy Labs. USD 10 Mln had been invested as of FY26.^[1]
Rampraveen Swaminathan was appointed Managing Director in Q3 FY26, succeeding Mr. Kannan.^[7]
Kutch highway construction raised logistics costs by ~INR 40 Cr YoY. It was expected to finish by end-September 2026.^[3]

Market Cap

₹5,922 Cr

High / Low

₹675 / 446

Stock P/E

61.9

Price / Book

3.1

Book Value

₹157

EPS

₹8.5

No. of Shares

12.35 Cr

ROCE

7.7%

ROE

5.5%

OPM

15.6%

Debt / Equity

0.24

Sales

₹1,081 Cr

Net Profit

₹105 Cr

Promoter holding

53.4%

Loading chart…

Signal history

AI Deep Dive

The analysis Screener can't give you

Our models read the latest earnings call, annual report, and financials end-to-end - then grade management, value the business, and flag the risks. Unlock all of it for this company:

Verdict
The headline call - descriptive label, conviction, and the synthesis behind it.
Valuation
Guidance-anchored P&L bridge - worst / average / best multiple cases.
Walk the talk
Did management deliver on past guidance? A commitment-by-commitment scorecard.
Red flags
Forensic and governance risk pointers, severity-ranked.
Balance sheet
Solvency and earnings-quality score.
Concall briefs
Quarter-by-quarter earnings-call briefs - what changed and why.

₹49 unlocks this company for 90 days, ₹299 for a full year - bundles bring it lower. Built on public disclosures - educational, not investment advice.

AI Deep Dive

Verdict

Locked

The headline call - descriptive label, conviction, and the synthesis behind it.

Company data

Financials